Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Post-marketing studies of new insulins: sales or science?

× No keyword cloud information.

13 in total

1. Unhealthy marketing of pharmaceutical products: An international public health concern.

Authors: Shai Mulinari
Journal: J Public Health Policy Date: 2016-02-25 Impact factor: 2.222

2. Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE.

Authors: Chantal Mathieu; Claes-Göran Ostenson; Stephan Matthaei; Matthew Reaney; Thure Krarup; Bruno Guerci; Jacek Kiljański; Carole Salaun-Martin; Hélène Sapin; Michael Theodorakis
Journal: Diabetes Ther Date: 2013-09-10 Impact factor: 2.945

3. Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.

Authors: Anna V Zetterqvist; Juan Merlo; Shai Mulinari
Journal: PLoS Med Date: 2015-02-17 Impact factor: 11.069

4. Economics and industry do not mean ethical conduct in clinical trials.

Authors: Joel Lexchin
Journal: J Pharm Policy Pract Date: 2013-12-02

Review 5. Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.

Authors: Xinji Zhang; Yuan Zhang; Xiaofei Ye; Xiaojing Guo; Tianyi Zhang; Jia He
Journal: BMJ Open Date: 2016-11-23 Impact factor: 2.692

6. Clinical drug trials in general practice: a 10-year overview of protocols.

Authors: Anja Maria Brænd; Kaspar Buus Jensen; Atle Klovning; Jørund Straand
Journal: Trials Date: 2013-06-01 Impact factor: 2.279

Review 7. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.

Authors: Isabelle Ramirez
Journal: Ger Med Sci Date: 2015-11-17

8. Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study.

Authors: Urpo Kiiskinen; Stephan Matthaei; Matthew Reaney; Chantal Mathieu; Claes-Göran Ostenson; Thure Krarup; Michael Theodorakis; Jacek Kiljański; Carole Salaun-Martin; Hélène Sapin; Bruno Guerci
Journal: Clinicoecon Outcomes Res Date: 2013-07-11

9. Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?

Authors: Nadia Barozzi; G M E E Geeske Peeters; Susan E Tett
Journal: BMC Health Serv Res Date: 2015-11-06 Impact factor: 2.655

10. The global intellectual property ecosystem for insulin and its public health implications: an observational study.

Authors: Warren A Kaplan; Reed F Beall
Journal: J Pharm Policy Pract Date: 2016-07-19